Efficacy of Dendritic Cells Matured Early with OK-432 (Picibanil®), Prostaglandin E2, and Interferon-α as a Vaccine for a Hormone Refractory Prostate Cancer Cell Line

다국어 초록 (Multilingual Abstract)

Dendritic cells (DCs) are potent antigen-presenting cells. OK432 (Picibanil®) was introduced as a potent stimulator of DC maturation in combination with prostaglandin-E2 and interferon-α. We compared the efficacy of a DC-prostate cancer vaccine using earlymature DCs stimulated with OK432, PGE2 and INF-α (OPA) with that of vaccines using other methods. On days 3 or 7 of DC culture, TNF-α (T), TNF-α and LPS (TL) or OPA were employed as maturation stimulators. DU145 cells subjected to heat stress were hybridized with mature DCs using polyethyleneglycol. T cells were sensitized by the hybrids, and their proliferative and cytokine secretion activities and cytotoxicity were measured. The yields of early-mature DCs were higher, compared to yields at the conventional maturation time (P<0.05). In the early maturation setting, the mean fusion ratios, calculated from the fraction of dual-positive cells, were 13.3%, 18.6%, and 39.9%, respectively (P=0.051) in the T only, TL, and OPA-treated groups. The function of cytotoxic T cells, which were sensitized with the hybrids containing DCs matured early with OPA, was superior to that using other methods. The antitumor effects of DC-DU145 hybrids generated with DCs subjected to early maturation with the OPA may be superior to that of the hybrids using conventional maturation methods.

참고문헌 (Reference)

1 Kaisho T, "Toll-like receptors and their signaling mechanism in innate immunity" 59 : 124-130, 2001

2 Shu YQ, "The effect of dendritic cells activated by OK-432 and pulsed with antigens on cytokine induced killers" 60 : 156-160, 2006

3 Koido S, "Synergistic induction of antigen-specific CTL by fusions of TLR-stimulated dendritic cells and heat-stressed tumor cells" 179 : 4874-4883, 2007

4 Koido S, "Synergistic induction of antigen-specific CTL by fusion of TLR-stimulated dendritic cells and heat stressed tumor cells" 179 : 4874-4883, 2007

5 Kao JY, "Superior efficacy of dendritic celltumor fusion vaccine compared with tumor lysate-pulsed dendritic cell vaccine in colon cancer" 101 : 154-159, 2005

6 Itoh T, "Streptococcal preparation OK432 promotes functional maturation of human monocyte-derived dendritic cells" 52 : 207-214, 2003

7 Koido S, "Streptococcal preparation OK-432 promotes fusion efficiency and enhances induction of antigen-specific CTL by fusions of dendritic cells and colorectal cancer cells" 178 : 613-622, 2007

8 Sakakibara M, "Quick generation of fully mature dendritic cells from monocytes with OK432, low-dose prostanoid, and interferon-α as potent immune enhancers" 29 : 67-77, 2006

9 Moldenhauer A, "Optimized culture conditions for the generation of dendritic cells from peripheral blood monocytes" 84 : 228-236, 2003

10 Toyokawa H, "Enhancement of circulating dendritic cell activity by immunomodulators (OK432 and KP-40)" 22 : 2137-2145, 2002

11 Tanaka F, "Efficient induction of specific cytotoxic T lymphocytes to tumor rejection peptide using functional matured 2 day-cultured dendritic cells derived from human monocytes" 29 : 1263-1268, 2006

12 Draube A, "Efficent activation of autologous tumor-specific T cells: a simple coculture technique of autologous dendritic cells compared to established cell fusion strategies in primary human colorectal carcinoma" 30 : 359-369, 2007

13 Kim KW, "Direct injection of immature dendritic cells into irradiated tumor induces efficient antitumor immunity" 109 : 685-690, 2004

14 Aiba S, "Dendritic cells differently respond to haptens and irritants by their production of cytokines and expression of co-stimulatory molecules" 27 : 3031-3038, 1997

15 Schuler G, "Dendritic cells as adjuvants for immune-mediated resistance to tumors" 186 : 1183-1187, 1997

16 Shimizu K, "Comparative analysis of antigen loading strategies of dendritic cells for tumor immunotheraphy" 27 : 265-272, 2004

17 Verhasselt V, "Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells: evidence for a soluble CD14-dependent pathway" 158 : 2919-2925, 1997

18 Larmonier N, "Apoptotic, necrotic, or fused tumor cells: an equivalent source of antigen for dendritic cell loading" 11 : 1513-1524, 2006

19 Lundqvist A, "Allogeneic tumor-dendritic cell fusion vaccines for generation of broad prostate cancer T-cell responses" 21 : 155-165, 2004

20 Caux C, "Activation of human dendritic cells through CD40 crosslinking" 180 : 1263-1272, 1994

21 Jakob T, "Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA" 161 : 3042-3049, 1998